Literature DB >> 24900419

Peptides and Pseudopeptides as SIRT6 Deacetylation Inhibitors.

Piia Kokkonen1, Minna Rahnasto-Rilla1, Päivi H Kiviranta1, Tero Huhtiniemi1, Tuomo Laitinen1, Antti Poso1, Elina Jarho1, Maija Lahtela-Kakkonen1.   

Abstract

SIRT6 belongs to the family of histone deacetylases (class III), but it also has mono-ADP-ribosyltransferase activity. SIRT6 is a nuclear sirtuin that has been associated with aging, cellular protection, and sugar metabolism. Despite these important roles for SIRT6, thus far, there are only a few weak SIRT6 inhibitors available, and no structure-activity relationship (SAR) studies have been published. This is the first study concerning peptides and pseudopeptides as SIRT6 deacetylation inhibitors and the first SAR data concerning SIRT6. We also investigated the molecular interactions using a homology model. We report three compounds exhibiting 62-91% SIRT6 inhibition at 200 μM concentration. These compounds can serve as starting points for systematic SAR studies and SIRT6 inhibitor design.

Entities:  

Keywords:  SIRT6; inhibitor; peptide; pseudopeptide; sirtuin; substrate-based inhibitor

Year:  2012        PMID: 24900419      PMCID: PMC4025866          DOI: 10.1021/ml300139n

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  26 in total

Review 1.  Are sirtuins viable targets for improving healthspan and lifespan?

Authors:  Joseph A Baur; Zoltan Ungvari; Robin K Minor; David G Le Couteur; Rafael de Cabo
Journal:  Nat Rev Drug Discov       Date:  2012-06-01       Impact factor: 84.694

2.  Genomic instability and aging-like phenotype in the absence of mammalian SIRT6.

Authors:  Raul Mostoslavsky; Katrin F Chua; David B Lombard; Wendy W Pang; Miriam R Fischer; Lionel Gellon; Pingfang Liu; Gustavo Mostoslavsky; Sonia Franco; Michael M Murphy; Kevin D Mills; Parin Patel; Joyce T Hsu; Andrew L Hong; Ethan Ford; Hwei-Ling Cheng; Caitlin Kennedy; Nomeli Nunez; Roderick Bronson; David Frendewey; Wojtek Auerbach; David Valenzuela; Margaret Karow; Michael O Hottiger; Stephen Hursting; J Carl Barrett; Leonard Guarente; Richard Mulligan; Bruce Demple; George D Yancopoulos; Frederick W Alt
Journal:  Cell       Date:  2006-01-27       Impact factor: 41.582

3.  Structure-based design of pseudopeptidic inhibitors for SIRT1 and SIRT2.

Authors:  Tero Huhtiniemi; Heikki S Salo; Tiina Suuronen; Antti Poso; Antero Salminen; Jukka Leppänen; Elina Jarho; Maija Lahtela-Kakkonen
Journal:  J Med Chem       Date:  2011-09-07       Impact factor: 7.446

4.  SIRT6 promotes DNA repair under stress by activating PARP1.

Authors:  Zhiyong Mao; Christopher Hine; Xiao Tian; Michael Van Meter; Matthew Au; Amita Vaidya; Andrei Seluanov; Vera Gorbunova
Journal:  Science       Date:  2011-06-17       Impact factor: 47.728

5.  Synthesis and characterization of SIRT6 protein coated magnetic beads: identification of a novel inhibitor of SIRT6 deacetylase from medicinal plant extracts.

Authors:  M Yasuda; D R Wilson; S D Fugmann; R Moaddel
Journal:  Anal Chem       Date:  2011-09-02       Impact factor: 6.986

6.  The sirtuin SIRT6 deacetylates H3 K56Ac in vivo to promote genomic stability.

Authors:  Bo Yang; Bernadette M M Zwaans; Mark Eckersdorff; David B Lombard
Journal:  Cell Cycle       Date:  2009-08-22       Impact factor: 4.534

7.  Cell cycle-dependent deacetylation of telomeric histone H3 lysine K56 by human SIRT6.

Authors:  Eriko Michishita; Ronald A McCord; Lisa D Boxer; Matthew F Barber; Tao Hong; Or Gozani; Katrin F Chua
Journal:  Cell Cycle       Date:  2009-08-26       Impact factor: 4.534

8.  SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin.

Authors:  Eriko Michishita; Ronald A McCord; Elisabeth Berber; Mitomu Kioi; Hesed Padilla-Nash; Mara Damian; Peggie Cheung; Rika Kusumoto; Tiara L A Kawahara; J Carl Barrett; Howard Y Chang; Vilhelm A Bohr; Thomas Ried; Or Gozani; Katrin F Chua
Journal:  Nature       Date:  2008-03-12       Impact factor: 49.962

9.  Human SIRT6 promotes DNA end resection through CtIP deacetylation.

Authors:  Abderrahmane Kaidi; Brian T Weinert; Chunaram Choudhary; Stephen P Jackson
Journal:  Science       Date:  2010-09-10       Impact factor: 47.728

10.  Structure-based development of novel sirtuin inhibitors.

Authors:  Christine Schlicker; Gina Boanca; Mahadevan Lakshminarasimhan; Clemens Steegborn
Journal:  Aging (Albany NY)       Date:  2011-09       Impact factor: 5.682

View more
  12 in total

1.  Sirtuin 6 (SIRT6) Activity Assays.

Authors:  Minna Rahnasto-Rilla; Maija Lahtela-Kakkonen; Ruin Moaddel
Journal:  Methods Mol Biol       Date:  2016

2.  Thiomyristoyl peptides as cell-permeable Sirt6 inhibitors.

Authors:  Bin He; Jing Hu; Xiaoyu Zhang; Hening Lin
Journal:  Org Biomol Chem       Date:  2014-10-14       Impact factor: 3.876

Review 3.  Biological and catalytic functions of sirtuin 6 as targets for small-molecule modulators.

Authors:  Mark A Klein; John M Denu
Journal:  J Biol Chem       Date:  2020-06-09       Impact factor: 5.157

Review 4.  Emerging roles of SIRT6 in human diseases and its modulators.

Authors:  Gang Liu; Haiying Chen; Hua Liu; Wenbo Zhang; Jia Zhou
Journal:  Med Res Rev       Date:  2020-12-16       Impact factor: 12.944

5.  Natural polyphenols as sirtuin 6 modulators.

Authors:  Minna Rahnasto-Rilla; Jonna Tyni; Marjo Huovinen; Elina Jarho; Tomasz Kulikowicz; Sarangan Ravichandran; Vilhelm A Bohr; Luigi Ferrucci; Maija Lahtela-Kakkonen; Ruin Moaddel
Journal:  Sci Rep       Date:  2018-03-07       Impact factor: 4.379

Review 6.  Sirtuins and SIRT6 in Carcinogenesis and in Diet.

Authors:  Maria de Céu Teixeira; Elena Sanchez-Lopez; Marta Espina; Maria Luisa Garcia; Alessandra Durazzo; Massimo Lucarini; Ettore Novellino; Selma B Souto; Antonello Santini; Eliana B Souto
Journal:  Int J Mol Sci       Date:  2019-10-07       Impact factor: 5.923

7.  Sirt6 Deacetylase: A Potential Key Regulator in the Prevention of Obesity, Diabetes and Neurodegenerative Disease.

Authors:  Swapnil Raj; Liston Augustine Dsouza; Shailendra Pratap Singh; Abhinav Kanwal
Journal:  Front Pharmacol       Date:  2020-12-07       Impact factor: 5.810

8.  Discovery of cryptic allosteric sites using reversed allosteric communication by a combined computational and experimental strategy.

Authors:  Duan Ni; Jiacheng Wei; Xinheng He; Ashfaq Ur Rehman; Xinyi Li; Yuran Qiu; Jun Pu; Shaoyong Lu; Jian Zhang
Journal:  Chem Sci       Date:  2020-11-02       Impact factor: 9.825

Review 9.  Sirtuin functions and modulation: from chemistry to the clinic.

Authors:  Vincenzo Carafa; Dante Rotili; Mariantonietta Forgione; Francesca Cuomo; Enrica Serretiello; Gebremedhin Solomon Hailu; Elina Jarho; Maija Lahtela-Kakkonen; Antonello Mai; Lucia Altucci
Journal:  Clin Epigenetics       Date:  2016-05-25       Impact factor: 6.551

10.  Small-molecule activating SIRT6 elicits therapeutic effects and synergistically promotes anti-tumor activity of vitamin D3 in colorectal cancer.

Authors:  Jialin Shang; Zhehui Zhu; Yingyi Chen; Jinglue Song; Yuji Huang; Kun Song; Jie Zhong; Xinyuan Xu; Jiacheng Wei; Chengxiang Wang; Long Cui; Chen-Ying Liu; Jian Zhang
Journal:  Theranostics       Date:  2020-04-27       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.